# Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel

> **NCT05199961** · NA · TERMINATED · sponsor: **Pack Health** · enrollment: 4 (actual)

## Conditions studied

- Lymphoma, Large B-Cell, Diffuse

## Interventions

- **BEHAVIORAL:** Digital Health Coaching

## Key facts

- **NCT ID:** NCT05199961
- **Lead sponsor:** Pack Health
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-25
- **Primary completion:** 2022-09-13
- **Final completion:** 2022-09-13
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Sponsor requested early termination
- **Last updated:** 2023-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05199961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05199961, "Quality of Life of Adults With Diffuse Large B-cell Lymphoma Treated With Tisagenlecleucel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05199961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*